“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

there could be a cure/preventative for breast cancer out there

They have a great product treating cancer with immunotherapy, peer reviewed journal

Alzheimer therapies are on the top of choices.

A drug that actually helps without any major side effects .. and breakthrough therapy. .

Better than chemo.

$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.

Successful 2b/3 trial for cancer drug.

"Cell therapies continue to present new promise with exciting breakthroughs happening throughout the vertical and TC BioPharm continues as a leader in the allogeneic gamma delta t-cellspace.

Phase 2/3 successful cancer drug .

Phase 2/3 successful cancer research .

$COSM gastric bypass and bariatric surgery will have a new competitor in the Clinical Weight Loss realm, one that is much less risky, Cosmos Health new weight loss product will revolutionize weight loss as it is much less invasive.